James Mackenzie

Head, GI/Neuroscience R&D Clinical Quality Assurance at Takeda Pharmaceuticals (formerly Nycomed) - Lexington, MA, US

James Mackenzie's Colleagues at Takeda Pharmaceuticals (formerly Nycomed)
Spiros Tzivelekis

Head Global Evidence & Outcomes Hematology

Contact Spiros Tzivelekis

Boris Karolicki

Head Global Clinical Development Medical Devices and Combination Products

Contact Boris Karolicki

Jason Durkin

Head, Device Supplier Relationship & External Operations

Contact Jason Durkin

Riddhi Shah

Associate Director, Head of In-Process Analytics

Contact Riddhi Shah

Helene Faessel

Group Head, Neuroscience Quantitative Clinical Pharmacology, Data Science Institute

Contact Helene Faessel

Sherry Popiolek

QA Head of Oncology Therapeutic Area Unit

Contact Sherry Popiolek

Andrew Harrison

Head of Global S&OP (Sales & Operations Planning)

Contact Andrew Harrison

View All James Mackenzie's Colleagues
James Mackenzie's Contact Details
HQ
224-554-6500
Location
New York,New York,United States
Company
Takeda Pharmaceuticals (formerly Nycomed)
James Mackenzie's Company Details
Takeda Pharmaceuticals (formerly Nycomed) logo, Takeda Pharmaceuticals (formerly Nycomed) contact details

Takeda Pharmaceuticals (formerly Nycomed)

Lexington, MA, US • >10000 Employees
Major Drugs

On October 1, 2011, Takeda Pharmaceutical Company Limited acquired Nycomed. Through the acquisition, Takeda, the largest pharma company in Asia, broadened its coverage of the global pharmaceutical market, especialy in Europe and emergig markets. More information on http://www.takeda.com. The below information is from before the acquisition: Nycomed is a privately owned global pharmaceutical company with a diversified portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. A range of OTC products completes the portfolio. Its R&D is structured around collaborations. In-licensing and expanding in emerging markets are cornerstones of the company's growth strategy. Nycomed employs 12,500 associates worldwide, and its products are sold in more than 100 countries. It has strong platforms in Europe and in fast-growing markets such as Russia/CIS, Latin America, Asia and the Middle East. In the US and Japan its products are available through best in class partners. Headquartered in Zurich, Switzerland, the company generated total sales of € 3.2 billion in 2010 and an adjusted EBITDA of € 851 million.

Branded Pharmaceuticals Gastroenterology Respiratory Conditions Inflammatory Diseases Pain Management Osteoporosis Treatment Over The Counter
Details about Takeda Pharmaceuticals (formerly Nycomed)
Frequently Asked Questions about James Mackenzie
James Mackenzie currently works for Takeda Pharmaceuticals (formerly Nycomed).
James Mackenzie's role at Takeda Pharmaceuticals (formerly Nycomed) is Head, GI/Neuroscience R&D Clinical Quality Assurance.
James Mackenzie's email address is ***@takeda.com. To view James Mackenzie's full email address, please signup to ConnectPlex.
James Mackenzie works in the Major Drugs industry.
James Mackenzie's colleagues at Takeda Pharmaceuticals (formerly Nycomed) are Spiros Tzivelekis, Boris Karolicki, Jason Durkin, Riddhi Shah, Helene Faessel, Sherry Popiolek, Andrew Harrison and others.
James Mackenzie's phone number is 224-554-6500
See more information about James Mackenzie